ursodeoxycholic acid has been researched along with Diathesis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowlus, C; Gao, L; Gershwin, ME; He, X; Leung, PSC; Wang, L; Woo, E; Yang, G | 1 |
| Nakanuma, Y; Sasaki, M; Sato, Y | 1 |
| Bian, Z; Ge, K; Han, X; Huang, F; Jia, W; Li, M; Qu, C; Rajani, C; Wang, S; Wei, M; Xie, G; Yang, W; Zhang, Y; Zhao, A; Zhao, L; Zheng, X | 1 |
| Joshita, S; Ota, M; Tanaka, E; Umemura, T | 1 |
| Tanner, MS; Taylor, CJ | 1 |
3 review(s) available for ursodeoxycholic acid and Diathesis
| Article | Year |
|---|---|
Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends.
Topics: Animals; Bile Acids and Salts; Biomarkers; Chenodeoxycholic Acid; Combined Modality Therapy; Disease Management; Disease Progression; Disease Susceptibility; Fibrosis; Humans; Immunotherapy; Liver Cirrhosis, Biliary; Liver Transplantation; Molecular Targeted Therapy; Severity of Illness Index; Symptom Assessment; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis.
Topics: Alleles; Cholangitis; Disease Susceptibility; Genetic Predisposition to Disease; Genome-Wide Association Study; HLA Antigens; Humans; Liver Cirrhosis, Biliary; Polymorphism, Genetic; Ursodeoxycholic Acid | 2017 |
Liver disease in cystic fibrosis.
Topics: Adolescent; Adult; Bile Duct Diseases; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Susceptibility; Genetic Therapy; Humans; Liver Diseases; Membrane Proteins; Ursodeoxycholic Acid | 1995 |
2 other study(ies) available for ursodeoxycholic acid and Diathesis
| Article | Year |
|---|---|
Increased p16
Topics: Animals; bcl-X Protein; Bile Ducts; Biomarkers; Case-Control Studies; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Disease Susceptibility; Epithelial Cells; Gene Expression; Humans; Liver Cirrhosis, Biliary; Mice; Ursodeoxycholic Acid | 2020 |
A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility.
Topics: Adipose Tissue, Brown; Animals; Body Mass Index; Chenodeoxycholic Acid; Cholestenones; Clostridiales; Cohort Studies; Diet, High-Fat; Disease Models, Animal; Disease Susceptibility; Gastrointestinal Microbiome; Gene Expression Regulation; Glucagon-Like Peptide 1; Humans; Ileum; Lithocholic Acid; Male; Metagenomics; Mice; Mice, Inbred C57BL; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Uncoupling Protein 1; Ursodeoxycholic Acid | 2020 |